We are live on ! Find out more
MDVN

MEDIVATION, INC.
MDVN

Delisted

MDVN was delisted on the 27th of September, 2016.

360 hedge funds and large institutions have $6.78B invested in MEDIVATION, INC. in 2016 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 133 increasing their positions, 119 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $76.6M | Put options by funds: $61.6M

12% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 51

12% more repeat investments, than reductions

Existing positions increased: 133 | Existing positions reduced: 119

1% more funds holding

Funds holding: 356360 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

6% less capital invested

Capital invested by funds: $7.22B → $6.78B (-$439M)

Holders
360
Holders Change
+4
Holders Change %
+1.12%
% of All Funds
9.59%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.29%
New
57
Increased
133
Reduced
119
Closed
51
Calls
$76.6M
Puts
$61.6M
Net Calls
+$15M
Net Calls Change
-$45.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.1B +$4.84M +133,464 +0.6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$538M +$11.9M +328,021 +3%
KCM
3
Knoll Capital Management
Florida
$202M
BIT
4
BlackRock Institutional Trust
California
$180M -$4.85M -133,613 -3%
State Street
5
State Street
Massachusetts
$169M +$9.37M +258,206 +8%
BFA
6
BlackRock Fund Advisors
California
$166M +$7.13M +196,457 +6%
JHIU
7
Janus Henderson Investors US
Colorado
$163M +$18.8M +519,567 +17%
TCM
8
TimesSquare Capital Management
New York
$144M +$10.1M +278,500 +10%
Deutsche Bank
9
Deutsche Bank
Germany
$142M +$25.2M +694,397 +29%
SCM
10
Scopia Capital Management
New York
$129M +$102M +2,804,911 New
BB
11
BB Biotech
Switzerland
$119M
IG
12
ING Group
Netherlands
$113M +$88.9M +2,451,367 +30,642%
Goldman Sachs
13
Goldman Sachs
New York
$101M +$21.1M +580,386 +36%
FCM
14
Frontier Capital Management
Massachusetts
$99.9M +$5.61M +154,535 +8%
DCM
15
Discovery Capital Management
Connecticut
$98.8M -$49.9M -1,374,408 -39%
PC
16
PointState Capital
New York
$95.1M +$75M +2,067,361 New
HM
17
HealthCor Management
New York
$92.7M -$10.3M -285,000 -12%
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$92.4M -$11.4M -315,000 -14%
Franklin Resources
19
Franklin Resources
California
$89.8M +$878K +24,200 +1%
RG
20
Redmile Group
California
$82.1M +$6.79M +187,206 +12%
CWAM
21
Columbia Wanger Asset Management
Illinois
$81.8M +$64.6M +1,780,000 New
JIM
22
Jupiter Investment Management
United Kingdom
$74.6M -$6.56M -180,985 -10%
BCPEM
23
Bain Capital Public Equity Management
Massachusetts
$69.8M +$14.8M +408,371 +37%
AQR Capital Management
24
AQR Capital Management
Connecticut
$69.2M -$62.4M -1,721,073 -53%
UBS AM
25
UBS AM
Illinois
$68.6M +$6.08M +167,675 +13%

MDVN Hedge Fund Activity: Q1 2016 in Review

360 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in MEDIVATION, INC. (MDVN) for Q1 2016, worth a combined $6.78B — down 6.1% from $7.22B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new MDVN positions and 51 closed out — a net gain of 6 holders — while 133 added to existing stakes and 119 trimmed.

The largest buyer was Scopia Capital Management, opening a new position worth an estimated $102M. The largest seller was Wells Fargo, cutting an estimated $166M.

  • 360 institutional investors held MEDIVATION, INC. (MDVN) as of Q1 2016, up from 356 in Q4 2015.
  • Funds reported $6.78B of MEDIVATION, INC. stock for Q1 2016, down 6.1% quarter-over-quarter.
  • 57 funds opened new MEDIVATION, INC. positions in Q1 2016 and 51 closed out, a net change of +6 holders.
  • The largest MEDIVATION, INC. buyer in Q1 2016 was Scopia Capital Management, an estimated $102M added.
  • The largest MEDIVATION, INC. seller in Q1 2016 was Wells Fargo, an estimated $166M sold.

Based on aggregated 13F filings for Q1 2016.